logo

Moehs group will be represented at CPHI Japan, which will be held from 18 to 20 March in Tokyo.

Moehs group will be represented at CPHI Japan, which will be held from 18 to 20 March in Tokyo.

Leave a Comment / By

CPhI Japan will take place at the Big Sight Exhibition Center in Tokyo (Japan) between March 18 and 20.

The CPhI Japan is, together with the CPhI China, the most important fair of the pharmaceutical industry in Asia. It is held once a year in Tokyo and only allows entry to the specialist public. The Japanese pharmaceutical industry is characterized by its quality and the high level of its medicines. It is an ideal environment for the most important suppliers and consumers of the pharmaceutical and chemical industry to inform themselves about market developments. This event is a great opportunity for exhibitors to create new customers and strengthen labor relations, as well as to enter international markets.

When?

From March 18 to 20, 2019

Where to find us?

We are visitors and represented by agents

Do you want to contact?

Contact us for any information and appointments at: info@moehs.es

 

Leave a Comment

Your email address will not be published. Required fields are marked *

logo
Twitter Linkedin-in
  • Headquarters:
  • Pol. Ind. Cova Solera
  • c/Roma, 8-12 08191 Rubí.
  • Barcelona (Spain)
  • T +34 93 586 05 20
  • Fax +34 93 588 85 13
  • info@moehs.es

Partnering companies

The Board of Directors of the Center for Technological Development and Innovation, E.P.E (CDTI), in its meeting held on 02/23/2023, approved the participation of this center in the research and development project called SYNTHESIS OF A STIMULATOR ACTIVE PRINCIPLE OF SOLUBLE CYCLASE GUANYLATE by granting partially reimbursable aid.

The objective is focused on the development of a new method of chemical synthesis of an active ingredient that stimulates soluble guanylate cyclase.

The project will be carried out at the Rubí facilities. The project execution period is from 2022 to 2024 and they have a financeable budget of €1,862,213.00.
This project is co-financed by the European Union and CDTI.

The Board of Directors of the Center for Technological Development and Innovation, E.P.E (CDTI), in its meeting held on 02/23/2023, approved the participation of this center in the research and development project called SYNTHESIS OF AN ACTIVE INHIBITOR PRINCIPLE OF JANUS KINASE FOR THE TREATMENT OF ATOPIC DERMATITIS.”, by granting partially reimbursable aid.

The objective is focused on the development of a new method of chemical synthesis of a janus kinase inhibitor active ingredient for the treatment of atopic dermatitis.

The project will be carried out at the Rubí facilities. The project execution period is from 2022 to 2025 and they have a financeable budget of €1,940,409.
This project is co-financed by the European Union and CDTI.